Member access

4-Traders Homepage  >  Shares  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA (MRK)

47
 SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Xetra
12/15/2014 12/16/2014 12/17/2014 12/18/2014 12/19/2014 Date
75.79(c) 77.8(c) 76.58(c) 77.87(c) 78.38(c) Last
740 518 955 690 591 787 642 376 872 760 Volume
-1.21% +2.65% -1.57% +1.68% +0.65% Change
More quotes
Company
Merck KGaA engages in the manufacturing of pharmaceutical and chemical products.The company operates through four divisions: Merck Serono, Consumer Health, Performance Materials & Merck Millipore.The Merck Serono division is biopharmaceutical division which markets both chemical and... 
Sector
Pharmaceuticals
Calendar
03/03Earnings Release
More about the company
Surperformance© ratings of Merck KGaA
Trading Rating : Investor Rating :
More Ratings
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MRK | DE0006599905 | 4-Traders
Full-screen chart
Financials (€)
Sales 2014 11 308 M
EBIT 2014 2 878 M
Net income 2014 1 378 M
Debt 2014 1 476 M
Yield 2014 1,34%
Sales 2015 12 111 M
EBIT 2015 2 461 M
Net income 2015 1 470 M
Finance 2015 93,8 M
Yield 2015 1,42%
PER 2014 25,30
PER 2015 23,35
EV / Sales 2014 1,03x
EV / Sales 2015 0,83x
Capitalization 10 130 M
More Financials
Latest news on MERCK KGAA
1d ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
4d ago MERCK KGAA : EMD Serono Continues Leadership Role in Product Integrity by Launch..
5d ago MERCK KGAA : EMD Millipore Assigned Patent
12/12 MERCK KGAA : Ethiopia will receive 13 Million Praziquantel Tablets in 2015; Merc..
12/12 MERCK KGAA : Ethiopia will receive 13 Million Praziquantel Tablets in 2015 Merck..
12/11 MERCK KGAA : EMD Serono launches app to help patients verify medicine
12/11 MERCK KGAA : EMD Serono Continues Leadership Role in Product Integrity by Launch..
12/11 MERCK KGAA : EMD Serono Awards Grant for Growth Countdown for Accepting Applicat..
More news
Sector news
12h ago MERCK : buys new-cancer-drug firm
20h ago Fear factor fades as global M&A hits seven-year high
1d ago AstraZeneca CEO says new Pfizer bid unlikely - Swedish daily DI
More sector news
4-Traders Strategies on MERCK KGAA 
04/10Prices move higher as positive news are released
03/10A gap-filling is anticipated
More Strategies


Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF